Olympus Corporation (OCPNY) Stock Analysis
DELISTED 2023
What happened to Olympus Corporation (OCPNY) stock?
Olympus Corporation (OCPNY) no longer trades on public markets. It was delisted in January 2023. The figures below are historical and are not a current quote.
- Status:
- Delisted — no longer trades
- Delisting date:
- January 2023
- Last recorded price (historical):
- $18.00 (last quote on record before the January 2023 delisting; historical, not a current quote)
P/E 31.44 means the share price is 31.44 times one year of earnings per share.
For informational purposes only. Not financial advice. Data sources: Financial Modeling Prep, Yahoo Finance, SEC EDGAR
Olympus Corporation (OCPNY). Olympus Corporation is a global medical technology and scientific solutions company, specializing in endoscopic, therapeutic, and scientific instruments. The company operates across diverse healthcare and industrial sectors, providing advanced equipment and services worldwide.
Last analyzed: Jun 15, 2026Olympus Corporation (OCPNY) Healthcare & Pipeline Overview
Olympus Corporation ADR Information Unsponsored
Olympus Corporation (OCPNY) trades in the U.S. as an American Depositary Receipt (ADR).
- ADR Level: 1
- ADR Ratio: 1:1
- Home Market Ticker: OCPN
OCPNY OTC Market Information
OCPNY trades on the OTC Other market tier of OTC Markets.
- OTC Tier: OTC Other
More about this archive record
Can I still buy OCPNY shares?
No. OCPNY stopped trading on public markets in January 2023, so the shares are not available through a broker. Anything you see quoted for OCPNY elsewhere is historical data, not a live market.
Are the figures on this page current?
No. Every number here is the last value recorded before OCPNY stopped trading. Nothing on this page updates, and none of it is a current quote.
Why does this page still exist?
Because people still search for what happened to Olympus Corporation. An archived profile that states the delisting plainly is more useful than a dead link — provided it is labelled as history, which is what this page does.
Disclaimer: This content is for informational purposes only and does not constitute investment advice. Always do your own research and consult a financial advisor.
Official Resources
Data provided for informational purposes only.